Emerging trends and challenges for pharmaceutical production

April 15, 2024

Remove from favorites

Add to favorites

The global pharmaceutical market, valued at around 1.25 trillion USD, is expected to grow steadily, with the United States leading in revenue generation. Despite the COVID-19 pandemic, pharmaceutical supply chains have proven resilient, and the industry is expected to remain unaffected by economic crises. Digital transformation, termed Pharma 4.0, is revolutionizing the industry, with AI, big data analysis, and predictive software at the forefront. Efficiency in production, especially in clinical trials, is crucial for speeding up time to market. Production control and monitoring are essential for ensuring product quality and safety, with automated systems and predictive software aiding in error detection and cost minimization. Serialization technology, used to assign unique codes to drug packaging, is becoming increasingly important and applicable across industries. COVID-19 has highlighted the need for simplified access to treatment and user-friendly medications, driving the demand for smarter pharmaceutical processes and improved production efficiency.